Humana (HUM) Teams Up with Vori Health and HOPCo to Enhance Patient Outcomes

Humana Inc. (NYSE:HUM) ranks among the best performing S&P 500 stocks in the last 3 months. In a bid to improve care for Medicare Advantage members with musculoskeletal conditions, Humana Inc. (NYSE:HUM) announced new value-based care agreements with Vori Health and HOPCo on August 27.

Valeri Potapova/Shutterstock.com

Through these collaborations, qualified Humana Medicare Advantage members will have access to care coordination teams that collaborate with their primary care physicians. These agreements also expand Humana’s established musculoskeletal care program, which comprises a partnership with TailorCare to serve Medicare Advantage members in Atlanta.

Humana Inc. (NYSE:HUM) is focused on improving health and well-being by providing a variety of healthcare benefits to its medical and specialty members. These include fully insured medical and specialty health insurance that covers vision, dental, and supplemental health benefits, as well as administrative services only (ASO) packages for individuals and employers.

While we acknowledge the potential of HUM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.